192 related articles for article (PubMed ID: 24563492)
21. Feline comorbidities: Pathophysiology and management of the obese diabetic cat.
Clark M; Hoenig M
J Feline Med Surg; 2021 Jul; 23(7):639-648. PubMed ID: 34167340
[TBL] [Abstract][Full Text] [Related]
22. Field safety and efficacy of protamine zinc recombinant human insulin for treatment of diabetes mellitus in cats.
Nelson RW; Henley K; Cole C;
J Vet Intern Med; 2009; 23(4):787-93. PubMed ID: 19566845
[TBL] [Abstract][Full Text] [Related]
23. [Case presentation from small animal medicine. Diabetes mellitus in a cat].
Borel N; Reusch C
Schweiz Arch Tierheilkd; 1999; 141(8):367-71. PubMed ID: 10475046
[TBL] [Abstract][Full Text] [Related]
24. Frequency of diabetic remission, predictors of remission and survival in cats using a low-cost, moderate-intensity, home-monitoring protocol and twice-daily glargine.
Gottlieb S; Rand JS; Anderson ST
J Feline Med Surg; 2024 Apr; 26(4):1098612X241232546. PubMed ID: 38661475
[TBL] [Abstract][Full Text] [Related]
25. Newer insulins in type 2 diabetes.
Gale EA
BMJ; 2012 Sep; 345():e4611. PubMed ID: 22968720
[No Abstract] [Full Text] [Related]
26. Retrospective evaluation of continuous rate infusion of regular insulin intravenously for the management of feline diabetic ketoacidosis.
Bollinger PN; Moore LE
Can Vet J; 2015 Jan; 56(1):35-8. PubMed ID: 25565711
[TBL] [Abstract][Full Text] [Related]
27. Glargine versus regular insulin protocol in feline diabetic ketoacidosis.
Zeugswetter FK; Luckschander-Zeller N; Karlovits S; Rand JS
J Vet Emerg Crit Care (San Antonio); 2021 Jul; 31(4):459-468. PubMed ID: 33945208
[TBL] [Abstract][Full Text] [Related]
28. Intensive blood glucose control is safe and effective in diabetic cats using home monitoring and treatment with glargine.
Roomp K; Rand J
J Feline Med Surg; 2009 Aug; 11(8):668-82. PubMed ID: 19592286
[TBL] [Abstract][Full Text] [Related]
29. Update on drugs used to treat endocrine diseases in small animals.
Behrend EN
Vet Clin North Am Small Anim Pract; 2006 Sep; 36(5):1087-105, vii. PubMed ID: 16984828
[TBL] [Abstract][Full Text] [Related]
30. The role of new basal insulin analogues in the initiation and optimisation of insulin therapy in type 2 diabetes.
Baxter MA
Acta Diabetol; 2008 Dec; 45(4):253-68. PubMed ID: 18766296
[TBL] [Abstract][Full Text] [Related]
31. Relationship between anti-insulin antibody production and severe insulin resistance in a diabetic cat.
Komiya T; Mori A; Nishii N; Oda H; Onozawa E; Seki S; Sako T
J Vet Med Sci; 2021; 83(4):661-665. PubMed ID: 33840723
[TBL] [Abstract][Full Text] [Related]
32. Editorial: glargine, a new long-acting insulin analog for diabetic cats.
Rand J
J Vet Intern Med; 2006; 20(2):219-20. PubMed ID: 16594574
[No Abstract] [Full Text] [Related]
33. Insulin detemir (levemir), a new long-acting insulin.
Med Lett Drugs Ther; 2006 Jul; 48(1238):54-5. PubMed ID: 16841022
[TBL] [Abstract][Full Text] [Related]
34. Management of cats on Lente insulin: tips and traps.
Caney SM
Vet Clin North Am Small Anim Pract; 2013 Mar; 43(2):267-82. PubMed ID: 23522172
[TBL] [Abstract][Full Text] [Related]
35. Insulin Therapy in Small Animals, Part 1: General Principles.
Fleeman L; Gilor C
Vet Clin North Am Small Anim Pract; 2023 May; 53(3):615-633. PubMed ID: 36906469
[TBL] [Abstract][Full Text] [Related]
36. Insulin degludec. Uncertainty over cardiovascular harms.
Prescrire Int; 2014 Jun; 23(150):149. PubMed ID: 25121146
[TBL] [Abstract][Full Text] [Related]
37. Feline diabetes mellitus: diagnosis, treatment, and monitoring.
Rios L; Ward C
Compend Contin Educ Vet; 2008 Dec; 30(12):626-39; quiz 639-40. PubMed ID: 19140103
[TBL] [Abstract][Full Text] [Related]
38. Preliminary study of protamine zinc recombinant insulin for the treatment of diabetes mellitus in cats.
Norsworthy G; Lynn R; Cole C
Vet Ther; 2009; 10(1-2):24-8. PubMed ID: 19742445
[TBL] [Abstract][Full Text] [Related]
39. Remission of diabetes mellitus in cats with diabetic ketoacidosis.
Sieber-Ruckstuhl NS; Kley S; Tschuor F; Zini E; Ohlerth S; Boretti FS; Reusch CE
J Vet Intern Med; 2008; 22(6):1326-32. PubMed ID: 19000245
[TBL] [Abstract][Full Text] [Related]
40. Glycemic variability in newly diagnosed diabetic cats treated with the glucagon-like peptide-1 analogue exenatide extended release.
Krämer AL; Riederer A; Fracassi F; Boretti FS; Sieber-Ruckstuhl NS; Lutz TA; Contiero B; Zini E; Reusch CE
J Vet Intern Med; 2020 Nov; 34(6):2287-2295. PubMed ID: 33001499
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
